GLPwatch

Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1

NCT07701460 · Not yet recruiting

Last updated 2026-07-27

This clinical trial is testing how well a GLP-1 medication helps people maintain their weight loss over time.

Status Not yet recruiting Approved but enrollment has not started.
Phase Not applicable Not a phased drug trial (e.g. a device or behavioral study).
Type Interventional (clinical trial)
Design Randomized, single-blind supportive care study
Participants 200 people Planned (estimated).
Who can join Ages 18+ · all sexes
Timeline Started 2026-08 · est. completion 2028-07
Where 1 site · United States

What this study is testing ClinicalTrials.gov NCT07701460 ↗

Description as written by the study sponsor.

Many people who use GLP-1 medications (such as semaglutide or tirzepatide) achieve meaningful weight loss, but maintaining that weight loss off after stopping the medication can be very challenging. Researchers at Tufts University are conducting a study to learn whether a digital lifestyle program can help people maintain their weight loss after they stop taking a GLP-1 medication. Adults who have recently stopped a GLP-1 medication may be eligible to participate. Participants will be randomly assigned to either receive access to a digital program or to continue with usual care. The study lasts 12 months and is fully remote. All participants will receive a Bluetooth scale to track weight from home and will complete short online questionnaires several times over the year. By taking part, participants can help researchers better understand how to support long-term weight maintenance in a way that is affordable, accessible, and sustainable. Participants are compensated for their time, and involvement may help improve care for others with similar experiences.

Treatments tested

Main thing measuredPercentage of weight loss maintained
SponsorTufts University
Conditions studiedWeight Maintenance
GLP-1 drugs

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07701460 ↗